---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-012214"
form_type: "8-K"
ticker: "AURX"
cik: "0001091596"
company_name: "Nuo Therapeutics, Inc."
filed_at: "2024-04-16T23:59:59+00:00"
generated_at: "2026-06-03T22:02:49.244755+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Nuo Therapeutics delays annual 10-K filing to April 19 for audit finalization

## Summary
- Company will not file Form 10-K by April 16 as previously expected.
- Delay due to independent auditor completing review of 2023 audited financial statements.
- Filing now expected by April 19, 2024.

## SEC filing metadata
- accession: 0001437749-24-012214
- form_type: 8-K
- ticker: AURX
- cik: 0001091596
- company_name: Nuo Therapeutics, Inc.
- filed_at: 2024-04-16T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1091596/000143774924012214/0001437749-24-012214-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1091596/000143774924012214/aurx20240416_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-012214
- JSON: https://secwatch.observer/filing/0001437749-24-012214.json
- Plain text: https://secwatch.observer/filing/0001437749-24-012214.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.